|
|
|
|
|
|
Kristin joined Health Advances in 2002 with extensive experience as a research scientist
in the diagnostics and drug discovery industries. Prior to joining Health Advances, Kristin
focused on diagnostics technology development at Genzyme and genomics research at Genome
Therapeutics
Kristin leads the Diagnostics and Discovery Tools Practice at Health Advances, a global practice which
meshes her consulting and scientific experience to provide results-oriented commercialization strategies
for her clients in the biotech and clinical diagnostics sectors, including focus on launch strategy,
pricing, and R&D prioritization for novel diagnostics and biotech platforms for the research laboratory,
personalized medicine, point-of-care, and mainstream clinical diagnostics. Her clients range from small
diagnostics and tools start-ups to the largest public companies and non-profit institutions in the
industry. Kristin is a frequent speaker, workshop leader and writer in the diagnostics and life sciences
industries, covering topics such as the future of point-of-care platforms, the commercialization of companion
diagnostics, and innovations in personalized medicine.
Kristin received her undergraduate degree in Biochemistry from Smith College and her Masters degree in
Epidemiology, Health Management, and Maternal and Child Health from the Harvard School of Public Health.
|
|
 |
|
|
|
|
